Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ORIC |
---|---|---|
09:32 ET | 3007 | 10.15 |
09:34 ET | 200 | 10.1 |
09:39 ET | 400 | 9.95 |
09:41 ET | 3600 | 9.955 |
09:43 ET | 1000 | 10.03 |
09:48 ET | 100 | 9.97 |
09:54 ET | 700 | 10.03 |
09:56 ET | 5965 | 9.97 |
09:57 ET | 2373 | 9.96 |
09:59 ET | 300 | 9.96 |
10:01 ET | 1653 | 9.995 |
10:03 ET | 200 | 9.97 |
10:06 ET | 673 | 9.96 |
10:08 ET | 100 | 9.94 |
10:10 ET | 2547 | 9.85 |
10:14 ET | 200 | 9.82 |
10:15 ET | 200 | 9.84 |
10:17 ET | 8337 | 9.8 |
10:19 ET | 909 | 9.785 |
10:21 ET | 100 | 9.75 |
10:24 ET | 7112 | 9.81 |
10:26 ET | 500 | 9.87 |
10:28 ET | 911 | 9.82 |
10:30 ET | 100 | 9.82 |
10:32 ET | 300 | 9.84 |
10:33 ET | 200 | 9.84 |
10:35 ET | 361 | 9.84 |
10:37 ET | 300 | 9.85 |
10:42 ET | 2112 | 9.8 |
10:44 ET | 600 | 9.85 |
10:46 ET | 2409 | 9.88 |
10:48 ET | 400 | 9.86 |
10:50 ET | 1822 | 9.88 |
10:53 ET | 300 | 9.89 |
10:55 ET | 817 | 9.7925 |
10:57 ET | 1022 | 9.8324 |
11:00 ET | 823 | 9.87 |
11:02 ET | 100 | 9.87 |
11:04 ET | 100 | 9.86 |
11:06 ET | 931 | 9.855 |
11:08 ET | 700 | 9.82 |
11:09 ET | 803 | 9.765 |
11:11 ET | 949 | 9.79 |
11:13 ET | 100 | 9.77 |
11:15 ET | 932 | 9.81 |
11:18 ET | 500 | 9.81 |
11:22 ET | 6765 | 9.7 |
11:24 ET | 1450 | 9.71 |
11:26 ET | 2006 | 9.7 |
11:27 ET | 400 | 9.7 |
11:29 ET | 3695 | 9.78 |
11:31 ET | 500 | 9.8 |
11:33 ET | 300 | 9.795 |
11:36 ET | 3509 | 9.85 |
11:38 ET | 1600 | 9.815 |
11:40 ET | 400 | 9.83 |
11:42 ET | 600 | 9.88 |
11:44 ET | 1404 | 9.9 |
11:45 ET | 337 | 9.91 |
11:47 ET | 616 | 9.922 |
11:49 ET | 685 | 9.89 |
11:51 ET | 542 | 9.87 |
11:54 ET | 800 | 9.875 |
11:56 ET | 100 | 9.88 |
12:02 ET | 1018 | 9.88 |
12:03 ET | 335 | 9.89 |
12:14 ET | 434 | 9.97 |
12:16 ET | 768 | 9.94 |
12:21 ET | 1470 | 9.94 |
12:23 ET | 100 | 9.97 |
12:30 ET | 285 | 9.95 |
12:32 ET | 100 | 9.97 |
12:36 ET | 1319 | 9.98 |
12:39 ET | 200 | 9.965 |
12:45 ET | 335 | 9.94 |
12:48 ET | 100 | 9.92 |
12:52 ET | 400 | 9.93 |
12:54 ET | 273 | 9.94 |
12:56 ET | 530 | 9.96 |
12:57 ET | 221 | 9.96 |
12:59 ET | 400 | 9.96 |
01:03 ET | 939 | 9.94 |
01:08 ET | 2658 | 9.88 |
01:17 ET | 207 | 9.84 |
01:19 ET | 450 | 9.83 |
01:21 ET | 200 | 9.8442 |
01:24 ET | 1200 | 9.85 |
01:26 ET | 100 | 9.82 |
01:28 ET | 100 | 9.83 |
01:30 ET | 100 | 9.83 |
01:33 ET | 556 | 9.85 |
01:35 ET | 641 | 9.895 |
01:37 ET | 300 | 9.89 |
01:42 ET | 100 | 9.89 |
01:46 ET | 512 | 9.92 |
01:48 ET | 100 | 9.92 |
01:50 ET | 100 | 9.905 |
01:51 ET | 400 | 9.91 |
01:53 ET | 200 | 9.94 |
01:55 ET | 162 | 9.94 |
01:57 ET | 200 | 9.95 |
02:02 ET | 567 | 9.97 |
02:06 ET | 4781 | 10.04 |
02:08 ET | 100 | 10.04 |
02:09 ET | 440 | 10.06 |
02:11 ET | 500 | 10.05 |
02:13 ET | 402 | 10.05 |
02:15 ET | 843 | 10.07 |
02:18 ET | 7999 | 10.095 |
02:20 ET | 825 | 10.08 |
02:22 ET | 649 | 10.1 |
02:26 ET | 400 | 10.11 |
02:27 ET | 999 | 10.12 |
02:31 ET | 1094 | 10.135 |
02:33 ET | 1440 | 10.1 |
02:36 ET | 302 | 10.08 |
02:40 ET | 500 | 10.055 |
02:47 ET | 776 | 10.05 |
02:54 ET | 100 | 10.045 |
02:58 ET | 600 | 10.03 |
03:00 ET | 4023 | 10.01 |
03:03 ET | 100 | 9.995 |
03:05 ET | 200 | 10.01 |
03:07 ET | 2299 | 10 |
03:09 ET | 5556 | 10.03 |
03:14 ET | 300 | 10.02 |
03:16 ET | 820 | 10.01 |
03:18 ET | 200 | 10.005 |
03:20 ET | 319 | 9.98 |
03:21 ET | 100 | 9.97 |
03:23 ET | 751 | 9.97 |
03:25 ET | 200 | 9.97 |
03:27 ET | 200 | 9.99 |
03:30 ET | 414 | 10.004 |
03:34 ET | 1000 | 9.985 |
03:36 ET | 200 | 9.985 |
03:38 ET | 1125 | 9.97 |
03:39 ET | 1679 | 9.999 |
03:41 ET | 786 | 10 |
03:43 ET | 972 | 10.02 |
03:45 ET | 1976 | 10 |
03:48 ET | 5785 | 9.95 |
03:50 ET | 5927 | 9.96 |
03:52 ET | 2999 | 9.96 |
03:54 ET | 4067 | 9.97 |
03:56 ET | 10125 | 10.01 |
03:57 ET | 6737 | 10.03 |
03:59 ET | 70570 | 10.04 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Oric Pharmaceuticals Inc | 723.1M | -5.7x | --- |
Terns Pharmaceuticals Inc | 703.9M | -6.2x | --- |
Savara Inc | 697.9M | -9.2x | --- |
Replimune Group Inc | 748.8M | -3.6x | --- |
Rapport Therapeutics Inc | 749.1M | -11.5x | --- |
Olema Pharmaceuticals Inc | 683.8M | -6.0x | --- |
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in improving patients' lives by overcoming resistance in cancer. It is developing a pipeline of clinical and discovery stage therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology and key tumor dependencies. Its clinical-stage product candidates include ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers, ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $723.1M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.11 |
EPS | $-1.76 |
Book Value | $4.08 |
P/E Ratio | -5.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.